Top 11 Healthcare Companies
11 Healthcare companies with latest reported revenue, headquarters and links to their sourced company profiles.
11 of these companies have a latest reported revenue figure, shown on their profiles with its fiscal year and source. This directory does not publish a combined sector revenue, because parent companies and subsidiaries and different revenue measures overlap.
Healthcare industry overview
Healthcare companies in this database span pharmaceutical manufacturers, medical device companies, hospital networks, and health insurance providers. Revenue and clinical milestones are drawn from the sources cited on each profile; those sources differ by company and claim. Analysis covers patent portfolios, drug pipelines and reimbursement where the record supports them.
This hub currently maps 11 organizations to Healthcare. The revenue spotlight uses each company's latest disclosed figure, converts non-US reporting currencies only for approximate ordering, and links to the underlying company profile for fiscal-year and source context.
UnitedHealth Group Incorporated
$447.6B (FY2025)
Top companies in this industry (by latest revenue)
UnitedHealth Group profile with 2025 revenue, CEO Stephen Hemsley, UnitedHealthcare, Optum, founder Richard Burke, and strategy.
McKesson profile: fiscal 2026 revenue, CEO Brian S. Tyler, pharmaceutical distribution, oncology, prescription technology, and healthcare competitors.
CVS Health profile: FY2025 revenue of $402.1B, Q2 2026 results, 2026 guidance, CEO David Joyner, Aetna, Caremark, Oak Street, competitors, and history since
Cencora profile covering history, FY2025 revenue, AmerisourceBergen roots, CEO Robert P. Mauch, pharmaceutical distribution, and strategy.
Cigna Group profile: $274.9B 2025 revenue, Q2 2026 results, CEO Brian Evanko, Express Scripts and Evernorth, the 2026 FTC insulin settlement, and history since
Cardinal Health profile: $254.2B FY2026 revenue, CEO Jason M.
Walgreens profile: the 2025 Sycamore take-private of WBA, CEO Mike Motz, FY2024 sales of $147.7B, store footprint changes and pharmacy strategy.
HCA Healthcare profile covering FY2025 revenue, profit, employees, leadership, history, business model, strategy, risks, and sources.
Tenet Healthcare company profile covering history, FY2025 revenue, founders, CEO Saum Sutaria, business model, and competitive strategy.
Labcorp profile covering FY2025 revenue, CEO Adam H. Schechter, diagnostic testing, biopharma lab services, and strategy.
All 11 companies in this industry (A-Z)
First 10 companies
Suggested company profiles
Tenet Healthcare company profile covering history, FY2025 revenue, founders, CEO Saum Sutaria, business model, and competitive strategy.
UnitedHealth Group profile with 2025 revenue, CEO Stephen Hemsley, UnitedHealthcare, Optum, founder Richard Burke, and strategy.
Labcorp profile covering FY2025 revenue, CEO Adam H. Schechter, diagnostic testing, biopharma lab services, and strategy.
Cardinal Health profile: $254.2B FY2026 revenue, CEO Jason M.
CVS Health profile: FY2025 revenue of $402.1B, Q2 2026 results, 2026 guidance, CEO David Joyner, Aetna, Caremark, Oak Street, competitors, and history since
Cigna Group profile: $274.9B 2025 revenue, Q2 2026 results, CEO Brian Evanko, Express Scripts and Evernorth, the 2026 FTC insulin settlement, and history since
McKesson profile: fiscal 2026 revenue, CEO Brian S. Tyler, pharmaceutical distribution, oncology, prescription technology, and healthcare competitors.
Cencora profile covering history, FY2025 revenue, AmerisourceBergen roots, CEO Robert P. Mauch, pharmaceutical distribution, and strategy.
Walgreens profile: the 2025 Sycamore take-private of WBA, CEO Mike Motz, FY2024 sales of $147.7B, store footprint changes and pharmacy strategy.
Top Healthcare Head-to-Head Comparisons
Cardinal Health vs Mckesson
McKesson is bigger than Cardinal Health by revenue and profit: $403.4 billion in revenue and $4.76 billion in net income for fiscal 2026 (ended March 31, 2026), versus Cardinal Health's $254.2 billion in revenue and $1.71 billion in net income for its fiscal 2026 (ended June 30, 2026). McKesson also converts more of each sales dollar into profit, with a net margin near 1.18% against Cardinal Health's roughly 0.67%. Cardinal Health employs more people (63,900) than McKesson (about 43,000) despite having smaller revenue, so McKesson produces substantially more revenue per employee.
Cencora vs Mckesson
McKesson is the bigger of the two Big Three drug distributors by revenue, reporting $403.4 billion for the fiscal year ended March 31, 2026, versus Cencora's $321.3 billion for the fiscal year ended September 30, 2025. McKesson is also far more profitable, with $4.76 billion of net income, a 1.18% net margin, against Cencora's $1.55 billion of net income attributable to Cencora, a 0.48% margin. McKesson's CEO is Brian S. Tyler, in the role since April 2019, while Cencora's CEO is Robert P. Mauch, who became president and CEO in October 2024.
Cigna vs Unitedhealth
UnitedHealth Group is bigger than The Cigna Group by every major measure for fiscal 2025: $447.6 billion versus $274.9 billion in revenue, about 390,000 versus 67,700 employees, and roughly $450 billion versus $71.9 billion in market capitalization in mid-to-late 2026. Despite UnitedHealth's much larger scale, its 2025 net margin of 2.7% (net income of $12.1 billion) narrowly beat Cigna's 2.2% (net income of $6.0 billion), even though UnitedHealth's earnings were depressed by a sharp rise in Medicare Advantage medical costs. UnitedHealth is run by CEO Stephen J. Hemsley, who returned in May 2025, while Cigna has been run by CEO Brian Evanko since July 1, 2026.
Cvs Health vs Unitedhealth
UnitedHealth Group is bigger than CVS Health by both revenue and market value: it reported $447.6 billion in revenue for fiscal 2025 versus CVS Health's $402.1 billion, and its market capitalization was about $450 billion on July 22, 2026 compared with CVS Health's roughly $110-120 billion in September 2026. UnitedHealth is also far more profitable, with $12.1 billion of 2025 net income (2.7% net margin) against CVS Health's $1.8 billion (0.4% net margin) after a $5.7 billion goodwill impairment at CVS's Oak Street Health unit. CVS Health's clearest scale edge is pharmacy benefits: its CVS Caremark unit held about 26% of U.S. PBM market share in 2025 versus Optum Rx's 23%.
Hca Healthcare vs Tenet Healthcare
HCA Healthcare is far bigger than Tenet Healthcare: it reported $75.6 billion of revenue in 2025 against Tenet's $21.31 billion, roughly 3.6 times as much, and employed about 320,000 people versus Tenet's 99,000. HCA also earned more in absolute profit, $6.784 billion of net income attributable to the company versus Tenet's $2.367 billion, but Tenet converted more of each revenue dollar into profit, with an 11.1% net margin in 2025 against HCA's 9.0%. Sam Hazen has been HCA's CEO since January 2019, and Dr. Saum Sutaria has been Tenet's CEO since September 1, 2021.
Cigna vs Elevance Health
Cigna is bigger by revenue: it reported $274.9 billion in total revenue for fiscal 2025, versus Elevance Health's $199.125 billion for the same year, a gap of about 38%. Elevance Health is more profitable on a margin basis, with a 2.84% net margin ($5.662 billion net income) compared with Cigna's 2.17% net margin ($5.957 billion net income), and it has more employees (97,100 versus 67,700). Cigna is led by CEO Brian Evanko since July 1, 2026, while Elevance Health has been run by CEO Gail K. Boudreaux since November 2017.
Related industries
Editorial Methodology
We use company filings, annual reports, company statements and press reports, with primary sources preferred where available. Each financial row shows its recorded source. Full-year figures are separated from annualized run-rates, partial periods and forecasts; unaudited figures carry a label. Source detail varies by company, so check the linked material when the reporting basis matters.
Public companies may provide filings and annual reports. Private-company figures may come from statements or press coverage. A missing figure stays missing, and a source link should identify where its number came from.
We organize company records and review claims for strategic context, source quality and clarity. Pages show a review date where one is recorded.
Technical checks flag inconsistent figures and missing links. Editorial review of the underlying source remains necessary for claims those checks cannot verify.
